TNF Pharmaceuticals - TNFA Company profit before taxes, interest and amortization
The prospects for TNF Pharmaceuticals (TNFA) are driven by small molecule trials and the potential for acquisition by industry behemoths. Absolute EBITDA dynamics visualize the current status, where the mark indicates the level of operating profit. Longevity research promises a breakthrough in immune correction, yet the absence of commercial products and reliance on external capital constrain financial growth.
TNF Pharmaceuticals, Inc. - analytical breakdowns and key metrics (TNFA)
- market value and analyst target forecast:
- issuer market value details:
- issuer book value statistics:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio TNF Pharmaceuticals|TNFA - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio TNF Pharmaceuticals Inc.|TNFA - Company Debts|Debt to Book Value Ratio TNF Pharmaceuticals|TNFA - Company Long-Term Debts|Current Liabilities TNF Pharmaceuticals|Intermediate Coverage Ratio tnfpharma.com
- earnings and market ratios statistics:
TNFA - Company Net Income|Forward Earnings TNF Pharmaceuticals|TNFA - P/E Multiple|Future Price to Earnings Multiple TNF Pharmaceuticals Inc.|TNFA - PEG Multiple|EV/EBITDA Multiple TNF Pharmaceuticals|TNFA - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year TNF Pharmaceuticals|TNFA - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months tnfpharma.com|TNFA - Earnings growth in current year|Earnings growth forecast for next year TNF Pharmaceuticals
Analysis of all company metrics:TNF Pharmaceuticals - TNFA
Absolute operating profit measures a business's ability to generate cash flow before depreciation and taxes, allowing for an assessment of cost of capital coverage through discounting. By analyzing actual operating profit, an investor identifies the resources available to compete, as a shortage of funds for clinical trials critically increases the risk of development failure for TNF Pharmaceuticals (TNFA) when facing global pharma behemoths.
Who TNF Pharmaceuticals competes with
Haleon Corp (HLN) - Profit before interest, taxes and amortization|KVUE: Operating profit before deduction of amortization|veronapharma.com - Company profit before taxes, interest and amortization|MENS: Operating profit EBITDA|Ligand Pharmaceuticals Incorporated - Income before deduction of interest, taxes and amortization|AMRX (Amneal Pharmaceuticals Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization Perrigo Corp PRGO|Profit before payment of interest, taxes and amortization Alvotech (ALVO)|LQDA (liquidia.com) - Income before deduction of interest, taxes and amortization|Galapagos - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization ANIP (ANI Pharmaceuticals Inc)|MNKD - Profit before payment of interest, taxes and amortization|AMPH (Amphastar Corp) - Operating profit before amortization|PCRX: Operating profit EBITDA|Profit before deduction of interest, taxes, depreciation and amortization SPRY (ars-pharma.com)|Operating profit before deduction of amortization TBPH|AQST: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization scPharmaceuticals Inc. (SCPH)|TECX: Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA TNXP (Tonix Pharmaceuticals)|Income before deduction of interest, taxes and amortization SXTC|Eupraxia Pharma - Operating profit EBITDA|BHST - Operating profit EBITDA|Invizyne Technologies, Inc. (EXOZ) - Profit before payment of interest, taxes and amortization|Oramed Pharmaceuticals Inc. - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Entera Bio Ltd|Operating profit before deduction of amortization ipatherapeutics.com (HYFT)|Operating profit EBITDA ABVC|Operating profit EBITDA Cumberland Pharmaceuticals Inc (CPIX)|Operating profit EBITDA QNTM (Quantum BioPharma Limited)|FGEN - Operating profit before deduction of amortization|Telomir Pharmaceuticals - Operating profit EBITDA|Profit before interest, taxes and amortization Rani Therapeutics|SNYR (synergychc.com) - Operating profit before deduction of amortization|Rallybio (RLYB) - Operating profit EBITDA|Operating profit before deduction of amortization LEXX|PULM (Pulmatrix Corporation) - Company profit before taxes, interest and amortization|Operating profit EBITDA PTHL|Operating income before deduction of amortization aptorumgroup.com|Operating profit EBITDA LYRA (Lyra Therapeutics)|IBO - Operating profit before deduction of amortization|cbdMD Corp - Operating profit EBITDA|PRFX - Operating profit EBITDA|altamiratherapeutics.com (CYTO) - Profit before payment of interest, taxes and amortization|LIPO (lipella.com) - Profit before payment of interest, taxes and amortization|Profit before payment of interest, taxes and amortization OptiNose|Pieris Pharmaceuticals Inc (PIRS) - Operating income before deduction of amortization|Operating profit before deduction of amortization PROC (Procaps Group SA)|Company profit before taxes, interest and amortization PTPI|Profit before payment of interest, taxes and amortization Qilian International QLI|SLRN: Operating profit before amortization|TFF Pharmaceuticals, Inc. - Operating profit EBITDA
